Nurix Therapeutics
Price & Volume
Stats
See more52W Range | $8.19-$22.50 |
Market Cap | $1.6B |
Shares Short | 19M |
Financials
See moreRevenue (12 Mos) | $71.7M |
Revenue Growth (YoY) | -66.1% |
Gross Profit (12 Mos) | -$259.5M |
Diluted EPS | -$3.17 |
News
See moreYahoo Finance • 5 days ago
Nurix Therapeutics Announces Bexobrutideg Oral Presentation at the 2026 European Hematology Association Congress
Yahoo Finance • 20 days ago
Nurix Therapeutics Inc. (NRIX): Leadership in Targeted Protein Degradation Attracts Smart Money
Yahoo Finance • 26 days ago
Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026
Yahoo Finance • last month
Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update
About
CEO | Dr. Arthur T. Sands M.D., Ph.D. |
Address | 1600 Sierra Point Parkway, Brisbane, CA, United States, 94005 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 317 |